TSH-receptor antibodies may prevent bone loss in pre- and postmenopausal women with Graves' disease and Graves' orbitopathy

ABSTRACT Objective Thyrotoxicosis is established risk factor for osteoporosis due to increased bone turnover. Glucocorticoids often administered for Graves' orbitopathy (GO) have additional negative effect on bone mineral density (BMD). Our aim was to examine the influence of thyroid hormones, TSH,...

Descripció completa

Dades bibliogràfiques

Autors principals:	Mira Siderova, Kiril Hristozov, Aleksandra Tsukeva
Format:	Artigo
Idioma:	Inglês
Publicat:	Sociedade Brasileira de Endocrinologia e Metabologia
Col·lecció:	Archives of Endocrinology and Metabolism
Matèries:	Graves' disease Graves' orbitopathy bone mineral density TSH-receptor antibodies osteoporosis
Accés en línia:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972018000200221&lng=en&tlng=en
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!